Sister chromatid exchanges in the lymphocytes of tuberculosis patients receiving short-term chemotherapy

Gopalrao V Velagaleti, E. V. Venkatarama Gupta, I. M. Thomas

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The frequency of sister chromatid exchanges was estimated in tuberculosis patients undergoing three different short term chemotherapy regimens (2SHRZ, 2HRZ and 2H2R2Z2), to evaluate the possible genetic damage caused by anti-Tuberculous drugs. Of the three combinations studied, two combinations (2SHRZ and 2HRZ), which were administered daily, enhanced the frequency of sister chromatid exchanges significantly (p < 0.05), while the third bi-weekly combination 2H2R2Z2), did not show any significant enhancement in the frequency of sister chromatid exchanges. These results are of importance in the treatment of tuberculosis, and indicate the need to select a drug combination that is equally efficient in the control of disease and at the same time less harmful to the genome of the patient.

Original languageEnglish (US)
Pages (from-to)173-176
Number of pages4
JournalTubercle
Volume71
Issue number3
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Sister Chromatid Exchange
Tuberculosis
Lymphocytes
Drug Therapy
Drug Combinations
Genome
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sister chromatid exchanges in the lymphocytes of tuberculosis patients receiving short-term chemotherapy. / Velagaleti, Gopalrao V; Venkatarama Gupta, E. V.; Thomas, I. M.

In: Tubercle, Vol. 71, No. 3, 1990, p. 173-176.

Research output: Contribution to journalArticle

@article{651d0d228b96424191a026f8ac81d55b,
title = "Sister chromatid exchanges in the lymphocytes of tuberculosis patients receiving short-term chemotherapy",
abstract = "The frequency of sister chromatid exchanges was estimated in tuberculosis patients undergoing three different short term chemotherapy regimens (2SHRZ, 2HRZ and 2H2R2Z2), to evaluate the possible genetic damage caused by anti-Tuberculous drugs. Of the three combinations studied, two combinations (2SHRZ and 2HRZ), which were administered daily, enhanced the frequency of sister chromatid exchanges significantly (p < 0.05), while the third bi-weekly combination 2H2R2Z2), did not show any significant enhancement in the frequency of sister chromatid exchanges. These results are of importance in the treatment of tuberculosis, and indicate the need to select a drug combination that is equally efficient in the control of disease and at the same time less harmful to the genome of the patient.",
author = "Velagaleti, {Gopalrao V} and {Venkatarama Gupta}, {E. V.} and Thomas, {I. M.}",
year = "1990",
doi = "10.1016/0041-3879(90)90071-F",
language = "English (US)",
volume = "71",
pages = "173--176",
journal = "Tubercle",
issn = "0041-3879",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Sister chromatid exchanges in the lymphocytes of tuberculosis patients receiving short-term chemotherapy

AU - Velagaleti, Gopalrao V

AU - Venkatarama Gupta, E. V.

AU - Thomas, I. M.

PY - 1990

Y1 - 1990

N2 - The frequency of sister chromatid exchanges was estimated in tuberculosis patients undergoing three different short term chemotherapy regimens (2SHRZ, 2HRZ and 2H2R2Z2), to evaluate the possible genetic damage caused by anti-Tuberculous drugs. Of the three combinations studied, two combinations (2SHRZ and 2HRZ), which were administered daily, enhanced the frequency of sister chromatid exchanges significantly (p < 0.05), while the third bi-weekly combination 2H2R2Z2), did not show any significant enhancement in the frequency of sister chromatid exchanges. These results are of importance in the treatment of tuberculosis, and indicate the need to select a drug combination that is equally efficient in the control of disease and at the same time less harmful to the genome of the patient.

AB - The frequency of sister chromatid exchanges was estimated in tuberculosis patients undergoing three different short term chemotherapy regimens (2SHRZ, 2HRZ and 2H2R2Z2), to evaluate the possible genetic damage caused by anti-Tuberculous drugs. Of the three combinations studied, two combinations (2SHRZ and 2HRZ), which were administered daily, enhanced the frequency of sister chromatid exchanges significantly (p < 0.05), while the third bi-weekly combination 2H2R2Z2), did not show any significant enhancement in the frequency of sister chromatid exchanges. These results are of importance in the treatment of tuberculosis, and indicate the need to select a drug combination that is equally efficient in the control of disease and at the same time less harmful to the genome of the patient.

UR - http://www.scopus.com/inward/record.url?scp=0025072608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025072608&partnerID=8YFLogxK

U2 - 10.1016/0041-3879(90)90071-F

DO - 10.1016/0041-3879(90)90071-F

M3 - Article

C2 - 2238122

AN - SCOPUS:0025072608

VL - 71

SP - 173

EP - 176

JO - Tubercle

JF - Tubercle

SN - 0041-3879

IS - 3

ER -